Age | Upper Respiratory Infection Absent
Item
subjects aged between 18 and 65，without acute upper respiratory tract infection for the past 2 weeks
boolean
C0001779 (UMLS CUI [1])
C0041912 (UMLS CUI [2,1])
C0332197 (UMLS CUI [2,2])
Chest X-ray Normal
Item
had a normal chest radiographic result
boolean
C0039985 (UMLS CUI [1,1])
C0205307 (UMLS CUI [1,2])
Percent predicted FEV1 Spirometry
Item
had a baseline spirometry with the forced expiratory volume in one second (fev1) of not less than 60% predicted
boolean
C0730561 (UMLS CUI [1,1])
C0037981 (UMLS CUI [1,2])
Withholding Treatment | Leukotriene Receptor Antagonist
Item
had withheld leukotriene receptor antagonists (ltra) for over 5 days
boolean
C0871549 (UMLS CUI [1])
C3537183 (UMLS CUI [2])
Withholding Treatment | Glucocorticoids Oral | Antihistamines Oral
Item
oral glucocorticosteroid or anti-histamine for 3 days
boolean
C0871549 (UMLS CUI [1])
C0017710 (UMLS CUI [2,1])
C1527415 (UMLS CUI [2,2])
C0019590 (UMLS CUI [3,1])
C1527415 (UMLS CUI [3,2])
Withholding Treatment | Xanthenes Oral | Bronchodilator Agents Active Long-term
Item
oral xanthenes or long-acting bronchodilators for 2 days
boolean
C0871549 (UMLS CUI [1])
C0043313 (UMLS CUI [2,1])
C1527415 (UMLS CUI [2,2])
C0006280 (UMLS CUI [3,1])
C0205177 (UMLS CUI [3,2])
C0443252 (UMLS CUI [3,3])
Withholding Treatment | Adrenal Cortex Hormones by Inhalation | Bronchodilator Agents Active Long-term | Bronchodilator Agents Active short-term
Item
inhaled corticosteroid or long-acting bronchodilator for a day as well as short-acting bronchodilator for 4 hours prior to the measurement
boolean
C0871549 (UMLS CUI [1])
C0001617 (UMLS CUI [2,1])
C0205535 (UMLS CUI [2,2])
C0006280 (UMLS CUI [3,1])
C0205177 (UMLS CUI [3,2])
C0443252 (UMLS CUI [3,3])
C0006280 (UMLS CUI [4,1])
C0205177 (UMLS CUI [4,2])
C0443303 (UMLS CUI [4,3])
FEV1 decreased Percentage | Status post Respiration Forced Repeated | Status post Inhalation Ethanol Diluent control
Item
subjects had a fall of no less than 15% in fev1 after repetitive forced respiration or a fall of no less than 20% in fev1 after the inhalation of ethanol diluent control
boolean
C4272903 (UMLS CUI [1,1])
C0439165 (UMLS CUI [1,2])
C0231290 (UMLS CUI [2,1])
C0035203 (UMLS CUI [2,2])
C0441722 (UMLS CUI [2,3])
C0205341 (UMLS CUI [2,4])
C0231290 (UMLS CUI [3,1])
C0205535 (UMLS CUI [3,2])
C0001962 (UMLS CUI [3,3])
C1875022 (UMLS CUI [3,4])
C0243148 (UMLS CUI [3,5])
Respiration Disorder | Exception Asthma | Chronic Obstructive Airway Disease | Bronchiectasis | Pulmonary Thromboembolism | Systemic disease Severe | Myocardial Infarction | Malignant Neoplasms
Item
had a past confirmed history of respiratory disease other than bronchial asthma (copd, bronchiectasis, pulmonary thromboembolism, etc.) or other severe systemic disease（myocardial infarction, malignant tumor, etc.）
boolean
C0035204 (UMLS CUI [1])
C1705847 (UMLS CUI [2,1])
C0004096 (UMLS CUI [2,2])
C0024117 (UMLS CUI [3])
C0006267 (UMLS CUI [4])
C0524702 (UMLS CUI [5])
C0442893 (UMLS CUI [6,1])
C0205082 (UMLS CUI [6,2])
C0027051 (UMLS CUI [7])
C0006826 (UMLS CUI [8])
Poor compliance Laboratory Procedures | Comprehension Limited | Immunocompromised patient | Study Subject Participation Status
Item
had a poor cooperation to the test or limited understandings, were immunocompromised, or had participated other clinical trials for the past 3 months.
boolean
C0032646 (UMLS CUI [1,1])
C0022885 (UMLS CUI [1,2])
C0162340 (UMLS CUI [2,1])
C0439801 (UMLS CUI [2,2])
C0085393 (UMLS CUI [3])
C2348568 (UMLS CUI [4])